MedPath

Levonorgestrel and Ethinyl Estradiol

Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1 mg/0.02 mg

Approved
Approval ID

6e686b50-8d36-4a13-91a8-d4ad21cdb735

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 19, 2023

Manufacturers
FDA

Lupin Pharmaceuticals, Inc.

DUNS: 089153071

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levonorgestrel and Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68180-854
Application NumberANDA091425
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levonorgestrel and Ethinyl Estradiol
Product Specifications
Effective DateDecember 19, 2023
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Levonorgestrel and Ethinyl Estradiol - FDA Drug Approval Details